Steve Wowk

Steve joined IDT as Vice President, Business Unit and General Management in July 2021. In this newly created role, Steve is leading IDT’s four business units (Custom Oligos & qPCR, Synthetic Biology, CRISPR & Functional Genomics, and Next Generation Sequencing) as the Company’s genomic technologies develop and expand from R&D tools to clinical solutions.

Steve has 25 years of experience in the life sciences industry. For the past five years, he was the Business Unit Director—Genomics at Beckman Coulter Life Sciences (BEC LS), with global responsibility for supporting strategic direction, innovation, new product development, strategic marketing, and in-market product management. Steve held management and sales positions at several leading companies, including MilliporeSigma, Bio-Rad Laboratories, and Pfizer, Inc.

Steve received a bachelor’s degree from the University of Dayton, Ohio, and a Master of Science degree from John Carroll University, Cleveland, Ohio. He also completed an Executive MBA program provided by the University of Texas, Austin.